Phase 4 N=517 Identifying Treatments to Motivate Smokers to Quit
Smoking · Smoking Cessation · Motivation
Primary: Percent Change in Cigarettes Smoked Per Day (CPD) — 38.7; 38.9; 37.4; 40.2 Percent Change in cigarettes per day — p=.98
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=849 A Novel Treatment to Boost Quit Attempts and Cessation Among Unmotivated Smokers
Smoking · Smoking Cessation
Primary: A Serious Quit Attempt in Which the Participant Intends to Permanently Stop Smoking — 208; 168 participants — p=0.008
N/A N=1,865 'Questions About Quitting' Smoking Cessation Trial
Smoking
Primary: Smoking Abstinence — 13.0; 13.8; 14.5; 13.3 percentage of abstinent participants
N/A N=225 The Get Quit - Stay Quit Study
Nicotine Dependent Cigarette Smoker
Primary: Number of Participants Reporting no Tobacco Use in the Past 7 Days and Have a Validated CO <10ppm — 61; 55 Participants — p=.65
N/A N=30 Quit or Switch: E-cigarette Study
Tobacco Use
Primary: Percentage of Participants Who Report Daily Use of E-cigarettes or NRT and no Cigarette Use
N/A N=350 Switching to a Vaping Device: Evaluating Risk Reduction Among Quitline Treatment Failures
Smoking, Cigarette
Primary: Proportion of Participants With Self-Reported 7-day Point Prevalence Abstinence From Cigarettes — 41; 33 Participants
N/A N=93 Evaluation of Learning-Theory-Based Smoking Cessation Strategies
Nicotine Dependence
Primary: 4-week Abstinence — 15; 17; 29; 20 participants
N/A N=22 Quit & Fit 2.0: Feasibility and Usability Testing
Smoking Cessation
Primary: Feasibility of the 6-week Tobacco Treatment Intervention — 14 Participants
Phase 4 N=1,316 Improving Quitline Support Study
Tobacco Use Cessation
Primary: 7-Day Point-Prevalence Abstinence — 11; 7; 8; 10 Participants
N/A N=3,120 TeleQuit Smoking Cessation Program
Smoking
Primary: 7-day Point Prevalence Abstinence From Smoking — 21; 16.4; 16.9; 16.5 percentage of participants
Phase 4 N=1,346 Smoking Cessation Intervention: Effectiveness in Primary Care
Tobacco Dependence
Primary: 6 Month Self-reported Abstinence From Smoking — 50; 52; 45; 75 participants
N/A N=314 Assessing the Effectiveness of a Pharmacist-delivered Smoking Cessation Program in the State of Qatar
Smoking Cessation
Primary: Self-reported 7-day Point Prevalence Abstinence — 26; 31 Participants
N/A N=319 Outcomes From a Mobile Smoking Cessation Program During a Monitoring Period of 6 Months
Smoking Cessation
Primary: Number of Participants Who Completed the Explore Stage — 283 Participants
Phase 4 N=270 Helping Those With Mental Illness Quit Smoking
Smoking · Nicotine Dependence · Mental Disorders
Primary: Acceptance of Wisconsin Tobacco Quit Line Services — 11; 6; 6 participants
N/A N=1,094 Implementation of Smoking Cessation Within NCI Community Oncology Research Program (NCORP) Sites
Smoking Cessation
Primary: Percentage of Patients With 7-day Sustained Smoking Abstinence Reported in the Patient Survey — 13.0; 13.5 percentage of participants — p=0.865
Phase 4 N=1,251 UW Quitting Using Intensive Treatment Study (QUITS)
Tobacco Dependence
Primary: 52-Week Point-Prevalence Abstinence — 74; 79; 78; 76 Participants — p=.66
Phase 4 N=1,270 Smoking Cessation in Hospitalized Smokers
Smoking Cessation
Primary: Percentage of Participants With 30-day Abstinence — 18.0; 23.4; 22.1; 18.7 percentage of participants
Phase 4 N=987 Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
Smoking · Smoking Cessation
Primary: 7-Day Point Prevalence Abstinence From Smoking by Intervention — 43.3; 48.9; 42.3; 49.9 Percentage of participants not smoking — p=.076
N/A N=6,009 Phase I Study: Stop Smoking Therapy for Ontario Patients (STOP)
Smoking
Primary: Count of Participants Not Smoking — 766 Participants
N/A N=1,647 An Innovative Conversational Agent (Quitbot) for Smoking Cessation
Smoking &Amp; Tobacco Cessation
Primary: Number of Participants With 30-day Cigarette Smoking Cessation — 191; 186 Participants — p=0.720
N/A N=121 Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy
Smoking
Primary: Number of Participants Who Stopped Smoking by 6 Month Post Treatment — 18; 14 participants
N/A N=1,973 Interventions to Help More Low-income Smokers Quit
Tobacco Use Cessation · Smoking Behaviors · Health Disparity
Primary: 7day Point Prevalence for Smoking — 78; 83 Participants
Phase 4 N=887 Distribution of Bupropion and Varenicline to Increase Smoking Cessation Attempts
Tobacco Use Disorder · Smoking · Smoking Cessation
Primary: 7-day Point Prevalence of Abstinence — 45; 22; 50 Participants
N/A N=40 QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt
Smoking · Smoking Cessation · Craving
Primary: Questionnaire on Smoking Urges Administered Daily Pre TMS to Measure Craving — 16; 12 units on a scale
N/A N=1,944 Helping Poor Smokers Quit
Smoking Cessation · Smoking, Tobacco · Smoking, Cigarette
Primary: Abstinence 6-months — 101; 90; 74; 103 Participants
N/A N=136 Relapse Prevention Through Social Networking Groups
Smoking
Primary: Self Reported Relapse Rate at 2 Months — 3; 10; 13 participants — p=0.033
Phase 3 N=320 EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking
Tobacco Smoking
Primary: Number of Participants With Continuous Abstinence at End-of-Treatment (EOT) as Assessed by Self-Report and Bio-verification — 64; 57 Participants
Phase 4 N=1,380 Impact Of Smoking Cessation Treatment Reimbursement On The Quit Rates In Smokers Motivated To Quit
Smoking Cessation · Insurance Coverage
Primary: Percentage of Participants With 7-Day Point Prevalence (PP) of Abstinence — 20.8; 13.9 Percentage of Participants — p=0.0007
N/A N=245 QuitBet Phase II: A Digital Social Game That Pays You to Stop Smoking
Smoking Cessation
Primary: Number of Participants Who Reported no Cigarette Smoking During the Past 7 Days — 30; 35 Participants
Phase 1 N=58 Persistence-Targeted Smoking Cessation
Tobacco Use Disorder
Primary: 7-day Point Prevalence Abstinence — 4; 1 participants